News
Stephanie Smieszek-Racine ’19 is the Vice Chair of the Women of WPI. This summer, the group, with support from the Alumni Association, is hosting a Vineyard Tour and Tasting event with WPI alumna ...
Takeda’s oveporexton improved wakefulness, attention and other key narcolepsy endpoints “with a high degree of statistical significance,” according to Jefferies analysts.
Endometrial Cancer is a type of cancer that begins in the lining of the uterus, most commonly affecting postmenopausal women. Rising prevalence due t ...
Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker. Weber – who was briefly chief operating officer of Takeda ...
Takeda has bought US biotech PvP Biologics for $330 million, adding a potential new form of therapy for coeliac disease to its pipeline.
Buying shares of beaten-down companies only makes sense if there are good reasons to expect them to bounce back. If that's not the case, stocks that may look cheap and attractive aren't actually so.
Get the latest Takeda Pharmaceutical Company Limited (TAK) stock news and headlines to help you in your trading and investing decisions.
View the latest Takeda Pharmaceutical Co. Ltd. ADR (TAK) stock price, news, historical charts, analyst ratings and financial information from WSJ.
See the latest Takeda Pharmaceutical Co Ltd stock price (4502:XTKS), related news, valuation, dividends and more to help you make your investing decisions.
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...
Ovarian Cancer Drugs Market grows as FDA, EMA fast-track advanced-stage therapies, boosting global approvals and innovation. Anurag Tiwari Orion Market Research Pvt Ltd + +91 91798 28694 email us here ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results